Publications by authors named "T Manhalter"
Article Synopsis
- The Edmonston-Zagreb measles vaccine is produced on chick-embryo fibroblasts or human diploid cells and has been safely administered to over 20 million people since its licensure in 1967.
- Studies show the vaccine maintains strong immunogenicity, with over 95% seroconversion in children aged 13-17 months and 100% response in infants aged 6-12 months after vaccination.
- The human diploid cell vaccine yields a significantly higher antibody response compared to chick-embryo fibroblast vaccine, regardless of age or administration route.
Live freeze-dried influenza A/New Jersey/76 vaccine prepared from the "cold-adapted variant" of NIB-3 strain. Three groups of about 50 persons were included in a double-blind placebo-controlled field trial. One group received the vaccine with 7 log EID50/dose, the other 6 log EID50/dose and the third received placebo.
View Article and Find Full Text PDF